PHAGENESIS
Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised ... a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
PHAGENESIS
Industry:
Biotechnology Health Care Medical
Founded:
2007-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.phagenesis.com
Total Employee:
11+
Status:
Active
Contact:
+44 161 820 4525
Total Funding:
29.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Phagenesis
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series B - Phagenesis
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series B - Phagenesis
Official Site Inspections
http://www.phagenesis.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Phagenesis"
Phagenesis - Crunchbase Company Profile & Funding
Sep 2, 2010 Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning …See details»
About - Phagenesis
Phagenesis Founded in 2007, Phagenesis is committed to scientific and clinical excellence in the development of novel therapies to treat patients suffering from neurogenic dysphagia. The …See details»
Phagenesis Company Profile 2024: Valuation, Funding …
Phagenesis General Information Description. Developer of a medical device designed to provide treatment of acute dysphagia. The company's device helps harness the brain's capacity for relearning functions that have been lost …See details»
Home United States - PHAGENESIS
If you are interested in joining our dynamic team, reach out to us at [email protected] or view our open positions on LinkedIn. View jobs. Get more information. For more information …See details»
Phagenesis Ltd - LinkedIn
At Phagenesis, we are dedicated to transforming the way dysphagia is treated. Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide.See details»
The staged acquisition of Phagenesis by Nestlé Health Science will ...
About Phagenesis® Phagenesis is headquartered in Manchester, UK, and focuses on the treatment of dysphagia. It was formed in 2007 to translate the research of Prof. Shaheen …See details»
Phagenesis, a medical device company specializing in the
Mar 4, 2024 Phagenesis® Ltd, is a private MedTech company co-founded by Dr. Conor Mulrooney and Professor Shaheen Hamdy from the University of Manchester in 2007. …See details»
Phagenesis Appoints Chad Hoskins as Chief Executive Officer …
Sep 5, 2024 Phagenesis, a pioneering company that has developed a first-of-its-kind neurostimulation system to treat swallowing dysfunction, today announced the appointment of …See details»
Phagenesis Company Profile - Office Locations, Competitors
Phagenesis is a company that develops a device to treat dysphagia. Its solution provides treatment for the cause of dysphagia which restores the neurological control of swallowing. …See details»
Phagenesis, a medical device company specializing in the …
Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M Series D financing all equity …See details»
Phagenesis - Funding, Financials, Valuation & Investors - Crunchbase
Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food. Search Crunchbase. ... How much funding has this …See details»
Phagenesis Appoints Chad Hoskins as Chief Executive Officer …
ABOUT PHAGENESIS Founded in 2007, Phagenesis® Ltd, is a private MedTech company co-founded by Dr. Conor Mulrooney and Professor Shaheen Hamdy from the University of …See details»
EQT Life Sciences leads USD 42 million funding round in Phagenesis
Mar 4, 2024 Amsterdam, The Netherlands, March 4, 2024 – EQT Life Sciences is pleased to announce that the EQT Health Economics strategy has invested in Phagenesis, a pioneering …See details»
Phagenesis, a medical device company specializing in the …
Mar 4, 2024 Phagenesis® Ltd, is a private MedTech company co-founded by Dr. Conor Mulrooney and Professor Shaheen Hamdy from the University of Manchester in 2007. …See details»
Phagenesis raises $42m to take medical device for swallowing …
Mar 4, 2024 K medtech startup Phagenesis has raised a $42m Series D to roll out its medical device for swallowing disorders in the US and expand its footprint in Europe. The round was …See details»
Meet the Makers: Phagenesis® | National Foundation of
Apr 25, 2023 Please note: The NFOSD is a nonprofit patient advocacy organization. We do not endorse specific products, treatments, or brands. ... in leading various global clinical education …See details»
Phagenesis - EQT Group
Latest news. 29 November 2024 EQT Exeter completes Spanish student housing portfolio sale to Azora; 26 November 2024 EQT portfolio company Parcel2Go announces new ownershipSee details»
Phagenesis - Dysphagia Research Society
Phagenesis is innovating the treatment of neurogenic dysphagia. Founded on 25+ years of scientific and clinical research, the Phagenyx® Pharyngeal Electrical Stimulation System …See details»
Largest real-world study of Phagenyx® demonstrates significant …
Nov 11, 2020 Phagenesis ® was formed in 2007 to translate the research of Professor Shaheen Hamdy (University of Manchester, UK), into an effective technology for standard clinical …See details»